IP Library Granted Patent US 7,252,086
Granted Patent B2
US 7,252,086 · App. 10/852,271 · Granted Aug 7, 2007

Lung reduction system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,252,086
App. No.
10/852,271
Granted
Aug 7, 2007
Kind
B2
Abstract

A pulmonary decompression device may be utilized to remove trapped air in the lung or lungs, thereby reducing the volume of diseased lung tissue. A lung reduction device may passively decompress the lung or lungs. In order for the system to be effective, an airtight seal between the parietal and visceral pleurae is required. Chemical pleurodesis is utilized for creating the seal.

Claims (9)

1. An implantable lung reduction device comprising:

at least one first implantable member in fluid communication, at a predetermined site, within a lung of a patient, the at least one implantable member passing through a lung via a passage created therethrough;

a sealing device for establishing an airtight seal between the at least one first implantable member and the lung; and

a second member connected to the at least one first implantable member, the second member comprising an apparatus configured for actively drawing air directly from the lung of the patient to vent to an area external of the lung and preventing air from an area external of the lung from re-entering the lung through the implantable lung reduction device, the second member being secured external of the lung.

2. An implantable lung reduction device comprising:

at least one first implantable member in fluid communication, at a predetermined site, within a lung of a patient, the at least one implantable member passing through a lung via a passage created therethrough;

a first sealing device for establishing an airtight seal between the at least one first member and the lung;

a second member connected to and in fluid communication with the at least one first implantable member, the second member comprising an apparatus configured for allowing air directly from the lung of the patient to vent to the ambient environment, and preventing air from the ambient environment from re-entering the lung through the device, the second member including a section positioned external of the body of the patient; and

a second sealing device for sealing the section positioned external of the body of the patient to the body.

Assignments (6)
CHANGE OF NAME Recorded Dec 3, 2007
From: RESPIRA, INC.
To: PORTAERO, INC.
Reel/Frame 020186/0043 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2007
From: NITINOL DEVELOPMENT CORPORATION
To: RESPIRA, INC.
Reel/Frame 019489/0689 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2007
From: CORDIS CORPORATION
To: NITINOL DEVELOPMENT CORPORATION
Reel/Frame 019466/0293 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2007
From: CORDIS CORPORATION
To: NITINOL DEVELOPMENT CORPORATION
Reel/Frame 019501/0961 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2006
From: TANAKA, DON
To: CORDIS CORPORATION
Reel/Frame 017628/0088 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2004
From: TANAKA, DON
To: CORDIS CORPORATION
Reel/Frame 015378/0434 →